ARTICLE | Clinical News

Multidrug resistance gene therapy with MDR-1 gene inserted into patients' stem cells isolated from blood: Ingenex Inc., one of Titan's operating companies, has

February 6, 1995 8:00 AM UTC

Titan Pharmaceuticals Inc., Menlo Park, Calif. Product: AN-9, based on butyric acid, which helps convert immature, rapidly dividing cells into differentiated cells, or to induce programmed cell death ...